Elias Jabbour

231PUBLICATIONS
312CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (231)

|Aug 13, 2026
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

|Jul 22, 2026
Results of second-line therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

|Jul 17, 2026
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

|Jul 16, 2026
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.

|Jul 04, 2026
Adult acute lymphoblastic leukemia: incorporation of recent advances into current treatment strategies.

|Jun 27, 2026
Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia.

Pageof 39

Frequent Collaborators

171 joint publications

Hagop M Kantarjian

133 joint publications

Tapan M Kadia

127 joint publications

Nicholas Short

104 joint publications

Navel G Daver